MyFinsight
Home
Blog
About
Short-term investments
$47,620K
Cash and cash
equivalents
$47,451K
(-11.81%↓ Y/Y)
Prepaid expenses
$1,357K
(-55.24%↓ Y/Y)
Other current assets
$376K
(-97.71%↓ Y/Y)
Operating lease
right-of-use assets
$120,468K
(0.22%↑ Y/Y)
Total current assets
$96,804K
(-20.19%↓ Y/Y)
Property and equipment,
net
$17,077K
(-28.33%↓ Y/Y)
Restricted cash
$13,691K
(0.00%↑ Y/Y)
Other assets
$1,000K
Total assets
$249,040K
(-10.74%↓ Y/Y)
Total liabilities and
stockholders equity
$249,040K
(-10.74%↓ Y/Y)
Total liabilities
$209,231K
(-4.09%↓ Y/Y)
Total stockholders
equity
$39,809K
(-34.59%↓ Y/Y)
Accumulated deficit
-$979,585K
(-23.73%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$9K
(10.00%↑ Y/Y)
Operating lease
liability, net of current
$103,506K
(-7.98%↓ Y/Y)
Deferred revenue, net of
current related party
$56,033K
(-5.92%↓ Y/Y)
Total current
liabilities
$31,692K
(-7.09%↓ Y/Y)
Research and development
funding liability
$18,000K
(50.00%↑ Y/Y)
Additional paid-in capital
$1,019,401K
(19.57%↑ Y/Y)
Common stock, par value
of 0.00001 per...
$2K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$8,978K
(-26.16%↓ Y/Y)
Operating lease liability
$8,972K
(23.62%↑ Y/Y)
Deferred revenue related
party
$7,934K
(-4.58%↓ Y/Y)
Accounts payable
$5,808K
(-8.94%↓ Y/Y)
Back
Back
Balance Sheet
Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. (PRME)
source: myfinsight.com